1. Adelaide Research & Scholarship

Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 31-40 of 47 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2013Smoking termination opportunity for in patients (STOP): Superiority of a course of varenicline tartrate plus counselling over counselling alone for smoking cessation: A 12-month randomised controlled trial for inpatientsSmith, B.; Carson, K.; Brinn, M.; Labiszewski, N.; Peters, M.; Fitridge, R.; Koblar, S.; Jannes, J.; Veale, A.; Goldsworthy, S.; Litt, J.; Edwards, D.; Esterman, A.
2007Kidney transplant rejection in Australia and New Zealand: Relationships between rejection and graft outcomeMcDonald, S.; Russ, G.; Campbell, S.; Chadban, S.
2010Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)Hughes, T.; Hochhaus, A.; Branford, S.; Muller, M.; Kaeda, J.; Foroni, L.; Druker, B.; Guilhot, F.; Larson, R.; O'Brien, S.; Rudoltz, M.; Mone, M.; Wehrle, E.; Modur, V.; Goldman, J.; Radich, J.
2012Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: Preclinical evaluation and results of the Phase II DUX Study in chemotherapy-refractory, advanced colorectal cancerWeickhardt, A.; Price, T.; Chong, G.; Gebski, V.; Pavlakis, N.; Johns, T.; Azad, A.; Skrinos, E.; Fluck, K.; Dobrovic, A.; Salemi, R.; Scott, A.; Mariadason, J.; Tebbutt, N.
2011Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up resultsKantarjian, H.; Giles, F.; Bhalla, K.; Pinilla-Ibarz, J.; Larson, R.; Gattermann, N.; Ottmann, O.; Hochhaus, A.; Radich, J.; Saglio, G.; Hughes, T.; Martinelli, G.; Kim, D.; Shou, Y.; Gallagher, N.; Blakesley, R.; Baccarani, M.; Cortes, J.; le Coutre, P.
2004Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancerSuwiwat, S.; Ricciardelli, C.; Tammi, R.; Tammi, M.; Auvinen, P.; Kosma, V.; LeBaron, R.; Raymond, W.; Tilley, W.; Horsfall, D.
2002Graft loss following renal transplantation in Australia: is there a centre effect?Briganti, E.; Wolfe, R.; Russ, G.; Eris, J.; Walker, R.; McNeil, J.
2001Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniaeBlack, P.; Blasi, F.; Jenkins, C.; Scicchitano, R.; Mills, G.; Rubinfeld, A.; Ruffin, R.; Mullins, P.; Dangain, J.; Cooper, B.; David, D.; Allegra, L.
2012The effects of pregabalin and the glial attenuator minocycline on the response to intradermal capsaicin in patients with unilateral sciaticaSumracki, N.; Hutchinson, M.; Gentgall, M.; Briggs, N.; Williams, D.; Rolan, P.; Ikeda, K.
2008Analgesic nephropathy and renal replacement therapy in Australia: Trends, Comorbidities and outcomesChang, S.; Mathew, T.; McDonald, S.

Discover